Sissetulev kiriAvalik
Farmakopöast kustutamine - Dextromoramide tartrate (0021)
Ravimiamet · 4. november 2024
- Viit
- REP-1/3999-1
- Registreeritud
- 4. november 2024
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Saabumis/saatmisviis
- e-post
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2024
- Vastutaja
- Signe Leito (RA, Labor)
Sisu (failidest)
Signe Leito
Saatja: [email protected]
Saatmisaeg: reede, 4. oktoober 2024 15:51
Adressaat: Signe Leito
Teema: Proposed suppression of the monograph on Dextromoramide tartrate 0021 from the Ph. Eur.: EDQM-2024-04041-mail
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Please make sure to include in any reply our mail reference: EDQM-2024-04041-mail
****************************************************************************
For the attention of NPAs
Copy: Presidium
Dear Colleagues,
Please find below the link to a survey being carried out concerning the proposed suppression of the monograph on Dextromoramide tartrate (0021) from the Ph. Eur.
In order to have access to the survey, please copy and paste this link into your Internet browser:
https://survey.edqm.eu/index.php?r=survey/index&sid=797236&lang=en
Deadline for replies: 8 November 2024
Thank you.
With kind regards
On behalf of Aurelie Barth
___
Villy Nikolova
Administrative Support Assistant
European Pharmacopoeia Department
EDQM
Council of Europe
Tel.: +33 (0)3 90 21 64 63 / Fax: +33
(0)3 88 41 27 71
https://www.edqm.eu / https://www.edqm.eu/store
Stay connected with the EDQM
1
****************************************************************************
Please make sure to include in any reply our mail reference: EDQM-2024-04041-mail
2